# Linaclotide for the treatment of chronic constipation.

> PubMed lists PMID 29985664 in Expert opinion on pharmacotherapy as Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2018-07-09 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-29985664-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-03-18
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-29985664-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-29985664-linaclotide-v1.json
- Content SHA-256: `ad39f844ce6b3472f7cd971b343562288f8a721cef602942de4147f298f9b0cd`

## Claims and source pins

### Headline

Linaclotide for the treatment of chronic constipation. ([`pubmed-observation-pmid-29985664-2019-03-18-0daca531a278`](#source-pubmed-observation-pmid-29985664-2019-03-18-0daca531a278))

### Summary

PubMed lists PMID 29985664 in Expert opinion on pharmacotherapy as Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2018-07-09 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-29985664-2019-03-18-0daca531a278`](#source-pubmed-observation-pmid-29985664-2019-03-18-0daca531a278))

### Paragraph 1

PubMed lists PMID 29985664 in Expert opinion on pharmacotherapy as Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2018-07-09 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-29985664-2019-03-18-0daca531a278`](#source-pubmed-observation-pmid-29985664-2019-03-18-0daca531a278))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-29985664-2019-03-18-0daca531a278`](#source-pubmed-observation-pmid-29985664-2019-03-18-0daca531a278))

## Sources

<a id="source-pubmed-observation-pmid-29985664-2019-03-18-0daca531a278"></a>
- **Linaclotide for the treatment of chronic constipation. · retained source version 1:2019-03-18:current:0daca531a2782f955cd8beedbf98674eb121ba0eb85a5b35e297b542d270732c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/29985664/) (`pubmed-observation-pmid-29985664-2019-03-18-0daca531a278`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Linaclotide for the treatment of chronic constipation." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-29985664-linaclotide-v1.json SHA-256: ad39f844ce6b3472f7cd971b343562288f8a721cef602942de4147f298f9b0cd.